[1]薛永平 肖维仁 王敏捷 胡卫列**.后腹腔镜下肾上腺部分与全部切除术治疗单侧醛固酮腺瘤的对比研究[J].中国微创外科杂志,2017,17(3):209-212.
　Xue Yongping,Xiao Weiren,Wang Minjie,et al.Retroperitoneal Laparoscopic Partial Versus Total Adrenalectomy for Unilateral Aldosterone-producing Adenoma[J].Chinese Journal of Minimally Invasive Surgery,2017,17(3):209-212.
点击复制

后腹腔镜下肾上腺部分与全部切除术治疗单侧醛固酮腺瘤的对比研究()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
17
期数:
2017年3期
页码:
209-212
栏目:
临床研究
出版日期:
2017-06-20

文章信息/Info

Title:
Retroperitoneal Laparoscopic Partial Versus Total Adrenalectomy for Unilateral Aldosterone-producing Adenoma
作者:
薛永平 肖维仁 王敏捷 胡卫列**
第二军医大学广州临床医学院广州军区广州总医院泌尿外科，广州510010
Author(s):
Xue Yongping;  Xiao Weiren;  Wang Minjie;  et al.
Department of Urology, Guangzhou General Hospital of Guangzhou Military Command of PLA;Guangzhou Clinical Medical College, Second Military Medical University, Guangzhou 510010, China
关键词:
原发性醛固酮增多症; 醛固酮腺瘤; 后腹腔镜; 肾上腺部分切除术; 肾上腺全部切除术
Keywords:
Primary hyperaldosteronism; Aldosterone-producing adenoma; Retroperitoneal laparoscopy; Partial adrenalectomy; Total adrenalectomy
文献标志码:
A
摘要:
目的比较后腹腔镜下肾上腺部分切除（partial adrenalectomy, PA）与全部切除（total adrenalectomy, TA）治疗单侧醛固酮腺瘤（aldosterone-producing adenoma, APA）的疗效。方法2006年1月~2012年12月，47例单侧APA接受手术治疗，其中36例行后腹腔镜下肾上腺部分切除术（PA组），11例行后腹腔镜下肾上腺全部切除术（TA组），比较2组患者术后血浆醛固酮浓度、血钾水平、血压水平、服用降压药物种类。结果均无术中输血及中转开腹。PA组和TA组手术时间分别为（116.5±37.0）、（100.2±42.8）min，无统计学差异（t=1.233，P=0.224）；术中出血量中位数分别为30 ml（5~400 ml）、20 ml（10~300 ml），差异无统计学意义（Z=-1.267，P=0.205）；禁食时间分别为（1.7±0.7）、（1.7±0.6）d，差异无统计学意义（t=0.000，P=1.000）；拔引流管时间分别为（3.0±0.8）、（2.8±0.9）d，差异无统计学意义（t=0.705，P=0484）；术后住院时间分别为（8.2±2.2）、（8.1±2.0）d，差异无统计学意义（t=0.135，P=0.894）。47例随访6~97个月（平均30个月），术后均无复发，无须补充血钾；2组患者高血压治愈率、改善率、无效率分别为（611%、25.0%、13.9%）和（63.6%、36.4%、0），差异无统计学意义（Z=-0.437，P=0.662）。结论对单侧肾上腺APA的手术治疗，后腹腔镜下PA技术上安全可行，疗效等同TA。
Abstract:
ObjectiveTo compare clinical effects between retroperitoneal laparoscopic partial and total adrenalectomy for unilateral aldosterone-producing adenoma (APA).MethodsFrom January 2006 to December 2012, 47 patients with unilateral APA were treated by surgery, including 36 cases of retroperitoneal laparoscopic partial adrenalectomy (PA group) and 11 cases of total adrenalectomy (TA group). A retrospective comparison about postoperative outcomes such as postoperative serum aldosterone, potassium level, blood pressure and number of antihypertensive drugs was performed between the two groups.Results There were no blood transfusions or conversions to open surgery. There were no differences in terms of operative time, blood loss, time for dieting, extubation time and postoperative hospital stay between the PA group and TA group ［(116.5±37.0) min vs. (100.2±42.8) min, t=1.233，P=0.224; median 30 ml (5-400 ml) vs. 20 ml (10-300 ml), Z=-1.267, P=0.205; (1.7±0.7) d vs. (1.7±0.6) d, t=0000, P=1.000; (3.0±0.8) d vs. (2.8±0.9) d, t=0.705, P=0.484; (8.2±2.2) d vs. (8.1±2.0) d, t=0135, P=0894］. Follow-ups for 6-97 months (mean, 30 months) found no recurrences and no requirements of potassium supplement. The two groups’ curative rates, improvement rates and ineffective rates were (61.1%, 25.0%, 13.9%) vs. (63.6%, 36.4%, 0), respectively, without significant differences between them (Z=-0.437, P=0.662).ConclusionFor the surgical treatment of patients with unilateral APA, retroperitoneal partial adrenalectomy is technically safe and feasible, with clinical effects equal to retroperitoneal total adrenalectomy.

参考文献/References:

[1]Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens,2013,31(7):1465-1471.
[2]Rayner B. Primary aldosteronism and aldosterone-associated hypertension. J Clin Pathol,2008,61(7):825-831.
[3]Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol,2006,48(11):2293-2300.
[4]Azizan EA, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet,2013,45(9):1055-1060.
[5]Elfenbein DM, Scarborough JE, Speicher PJ, et al. Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project. J Surg Res,2013,184(1):216-220.
[6]薛永平，胡卫列.肾上腺皮质黑色腺瘤的诊断与治疗（附7例报告）.中国微创外科杂志,2016,16(7):617-620, 631.
[7]Zarnegar R, Young WF, Lee J, et al. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg,2008,247(3):511-518.
[8]Fu B, Zhang X, Wang GX, et al. Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol,2011,185(5):1578-1582.
[9]Imai T, Tanaka Y, Kikumori T, et al. Laparoscopic partial adrenalectomy. Surg Endosc,1999,13(4):343-345.
[10]Sommerey S, Foroghi Y, Chiapponi C, et al. Laparoscopic adrenalectomy-10-year experience at a teaching hospital. Langenbecks Arch Surg,2015,400(3):341-347.
[11]Jeschke K, Janetschek G, Peschel R, et al. Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results. Urology,2003,61(1):69-72.
[12]Ishidoya S, Ito A, Sakai K, et al. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol,2005,174(1):40-43.
[13]Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab,2016,101(5):1889-1916.
[14]Otto M, Dzwonkowski J. Adrenal-preserving surgery of adrenal tumours. Endokrynol Pol,2015,66(1):80-96.
[15]Quillo AR, Grant CS, Thompson GB, et al. Primary aldosteronism: results of adrenalectomy for nonsingle adenoma. J Am Coll Surg,2011,213(1):106-112.
[16]Weisbrod AB, Webb RC, Mathur A, et al. Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism. Ann Surg Oncol,2013,20(3):753-758.
[17]Chen SF, Chueh SC, Wang SM, et al. Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: partial versus total adrenalectomy. J Endourol,2014,28(9):1103-1106.
[18]Lumachi F, Ermani M, Basso SM, et al. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg,2005,71(10):864-869.
[19]Rossi GP, Bolognesi M, Rizzoni D, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension,2008,51(5):1366-1371.
[20]Mourad JJ, Girerd X, Milliez P, et al. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Am J Hypertens,2008,21(7):742-747.
[21]Wachtel H, Cerullo I, Bartlett EK, et al. Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism. Surgery,2014,156(6):1394-1402.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（项目编号：81172421）**通讯作者，E-mail: huwl-mr@vip.sina.com
更新日期/Last Update: 2017-06-20